公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer | BIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG | Current Opinion in Oncology | 122 | 109 | |
2019 | Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients | BIN-CHI LIAO ; Griesing S.; CHIH-HSIN YANG | Therapeutic Advances in Medical Oncology | 27 | 25 | |
2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
2022 | Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis | HSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG | BMC cancer | 2 | 2 | |
2018 | Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials? | BIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG | Expert Opinion on Pharmacotherapy | 5 | 5 | |
2015 | Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy | BIN-CHI LIAO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG | Therapeutic Advances in Medical Oncology | 16 | 16 | |
2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
2016 | Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors | BIN-CHI LIAO ; CHIA-CHI LIN ; JIH-HSIANG LEE ; CHIH-HSIN YANG | Journal of Biomedical Science | 43 | 37 | |
2022 | 肺癌用藥 你該知道的事 | 臺大癌醫中心分院肺癌多專科診療團隊; JIN-SHING CHEN ; 莊仁豪; BIN-CHI LIAO ; 劉彥廷; YEN-TING LIN; ZONG-HAN YAO ; SHANG-GIN WU ; SHU-WEN LIN ; 何暐; 柯欣妏 |